Moberg Pharma AB reports FQ2 results

Feb. 09, 2021 6:31 AM ETMoberg Pharma AB (publ) (MBGRF)MBGRFBy: Niloofer Shaikh, SA News Editor
  • Moberg Pharma AB (OTC:MBGRF): FQ2 GAAP EPS of -SEK0.30.
  • Cash and cash equivalents of SEK29.3M.
  • Press Release

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.